Synthesis of cephalosporin compounds

US10214543B2 · US · B2

Patent metadata
FieldValue
Publication numberUS-10214543-B2
Application numberUS-201515540283-A
CountryUS
Kind codeB2
Filing dateDec 18, 2015
Priority dateDec 30, 2014
Publication dateFeb 26, 2019
Grant dateFeb 26, 2019

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

Described herein are methods for the manufacture of ceftolozane and related compounds, as well as compositions comprising the same.

First claim

Opening claim text (preview).

What is claimed is: 1. A process of making a compound of formula (V′): comprising admixing a compound of formula (III′): and a compound of formula (IV′): in a solvent to provide the compound of formula (V′), wherein: P 1 and P 2 are each independently an acid-labile nitrogen protecting group, P 3 and P 4 are each independently an acid-labile oxygen protecting group, X − is a pharmaceutically acceptable salt, Y is Cl or Br; the molar ratio of the compound of formula (IV′) to the compound of formula (III′) is from 1.0:1 to 1.3:1; and the solvent is purged with nitrogen at from 0.2 m 3 /h to 1.2 m 3 /h per kilogram of the compound of formula (III′). 2. A process of making a compound of formula (V′): comprising admixing a compound of formula (III′): and a compound of formula (IV′): in a solvent to provide the compound of formula (V′), wherein: P 1 and P 2 are each independently an acid-labile nitrogen protecting group, P 3 and P 4 are each independently an acid-labile oxygen protecting group, X − is a pharmaceutically acceptable salt, Y is Cl, Br or I; the temperature of the admixture is from 25° C. to 32° C.; and the solvent is purged with nitrogen at from 0.2 m 3 /h to 1.2 m 3 /h per kilogram of the compound of formula (III′). 3. A process of making a compound of formula (V′): comprising admixing a compound of formula (III′): and a compound of formula (IV′): in a solvent to provide the compound of formula (V′), wherein: P 1 and P 2 are each independently an acid-labile nitrogen protecting group, P 3 and P 4 are each independently an acid-labile oxygen protecting group, X − is a pharmaceutically acceptable salt, Y is Cl, Br or I; and the solvent is purged with nitrogen at from 0.2 m 3 /h to 1.2 m 3 /h per kilogram of the compound of formula (III′). 4. The process of claim 1 , 2 or 3 , wherein P 1 is tert-butoxycarbonyl. 5. The process of claim 1 , 2 or 3 , wherein P 2 is triphenylmethyl. 6. The process of claim 1 , 2 or 3 , wherein P 3 is 4-methoxybenzyl. 7. The process of claim 1 , 2 or 3 , wherein P 4 is tert-butyl. 8. The process of claim 1 , 2 or 3 , wherein X − is trifluoroacetate, bromide, chloride, iodide, or methanesulfonate. 9. The process of claim 1 , 2 or 3 , wherein Y is Cl. 10. The process of claim 1 , 2 or 3 , wherein the admixture further comprises 1, 3-bis(trimethylsilyl)urea. 11. The process of claim 1 , 2 or 3 , wherein the admixture further comprises potassium iodide. 12. The process of claim 1 , 2 or 3 , wherein the temperature is from 27° C. to 30° C. 13. The process of claim 1 , 2 or 3 , wherein the solvent is a polar aprotic solvent. 14. The process of claim 1 , 2 or 3 , wherein the solvent comprises N-methylpyrrolidinone. 15. The process of claim 1 , 2 or 3 , wherein the solvent is purged with nitrogen at from 0.3 m 3 /h to 1.2 m 3 /h per kilogram of the compound of formula (III′). 16. The process of claim 1 , 2 or 3 , wherein the molar ratio of the compound of formula (IV′) to the compound of formula (III′) is 1.2:1. 17. The process of claim 1 , 2 or 3 , wherein the compound of formula (V′) has the structure of compound (V): the compound of formula (III′) has the structure of compound (III): and the compound of formula (IV′) has the structure of compound (IV): 18. The process of claim 1 , 2 or 3 , further comprising making a compound of formula (Vb′): comprising contacting the compound of formula (V′) with an acid of formula HX, at a temperature of from 18° C. to 22° C., to provide the compound of formula (Vb′), wherein HX is trifluoroacetic acid, hydrogen bromide, hydrogen chloride, hydrogen iodide, or methanesulfonic acid; and X′ is trifluoroacetate, bromide, chloride, iodide, or methanesulfonate. 19. The process of claim 18 , wherein the amount of the acid is from 4.5 L to 6.0 L per kilogram of the compound of formula (V′). 20. The process of claim 18 , further comprising separating the compound of formula (Vb′) at a temperature of from −40° C. to −30° C.

Assignees

Inventors

Classifications

  • C07D501/56Primary

    with the 7-amino radical acylated by carboxylic acids containing hetero rings · CPC title

  • of amide groups · CPC title

  • of amino groups · CPC title

  • Introduction of protecting groups or activating groups, not provided for in the preceding groups · CPC title

  • containing three or more hetero rings · CPC title

Patent family

Related publications grouped by family.

External sources

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US10214543B2 cover?
Described herein are methods for the manufacture of ceftolozane and related compounds, as well as compositions comprising the same.
Who is the assignee on this patent?
Merck Sharp & Dohme
What technology area does this patent fall under?
Primary CPC classification C07D501/56. Mapped technology areas include Chemistry & Metallurgy.
When was this patent published?
Publication date Tue Feb 26 2019 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 3 related publications on this page (citations in our corpus or others sharing the same primary CPC).